Skip to main content
Standard first‐line chemotherapies for indolent B‐cell lymphoma impose varying risks for a second cancer
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Standard first‐line chemotherapies for indolent B‐cell lymphoma impose varying risks for a second cancer
User login
Username
Password
Reset your password
Concept
Lead
score
Non-Hodgkin Lymphoma (NHL)
1
1
Antineoplastic Drug
0
1
Biologic Therapy
0
1
Indolent Lymphoma
0
0.85
Secondary Neoplasm
0
0.85
Monoclonal Antibody
0
0.75
Lymphoma
0
0.47
B-Cell Lymphoma
0
1
Cancer
0
0.37
Chemotherapy
0
0.75
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
1
Edit Tags